CClinicalTrials.gg
RecruitingNCT07539142Updated Jun 2, 2026

The HVIP+ Community Model

An interventional study of Brief Bedside and Peer Support in Hospital-based Violence Intervention, Community Firearm Violence and Firearm Behaviors, sponsored by University of Arkansas. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by University of Arkansas · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.

Read the detailed description

Arkansas is a rural southern state with a high toll of homicide relative to its total population (AR ranks 8th nationally in firearm homicide rates). This study will engage community partners throughout Central Arkansas in a multi-level, multi-faceted intervention to reduce the toll of violent assault on individuals and communities. An optimization randomized control trial (ORCT) design will be used to test the preliminary efficacy of a multi-level intervention with an explicit focus on secondary violence prevention through hospital-community partnerships to prevent escalation of firearm violence among survivors living in counties in Central Arkansas, the region of the state where violent assault is greatest. The study will also incorporate key implementation science metrics to evaluate the feasibility and reach of the proposed intervention.

02

Conditions studied

  • Hospital-based Violence Intervention
  • Community Firearm Violence
  • Firearm Behaviors
03

In context

Lead sponsor

University of Arkansas is the lead sponsor of 391 studies on the registry; 39 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 34 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Be at least 18 years of age or older
  • Currently live in Central Arkansas
  • Currently being treated for a penetrating gun assault injury at a local hospital

Exclusion criteria

Exclusion Criteria:

Participants must not:

  • Report any medical problems that would limit their ability to express thoughts and answer questions (i.e. active intoxication, developmental delays, dementia, psychosis, etc.)
  • Be currently under arrest or in police custody
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
208 participants (estimated)

Study arms

  • Experimental
    BB, CM, G

    Participants receive brief bedside, case management+ voucher, and SELF group intervention components.

    Behavioral: Brief Bedside · Behavioral: Case Management + Voucher · Behavioral: SELF Group Therapy Sessions

  • Experimental
    BB, CM

    Participants receive brief bedside and case management+ voucher intervention components.

    Behavioral: Brief Bedside · Behavioral: Case Management + Voucher

  • Experimental
    BB, G

    Participants receive brief bedside and SELF group intervention components.

    Behavioral: Brief Bedside · Behavioral: SELF Group Therapy Sessions

  • Experimental
    BB

    Participants receive brief bedside intervention component.

    Behavioral: Brief Bedside

  • Experimental
    ALL

    Participants receive brief bedside, peer support, case management+ voucher, and SELF group intervention components.

    Behavioral: Brief Bedside · Behavioral: Peer Support · Behavioral: Case Management + Voucher · Behavioral: SELF Group Therapy Sessions

  • Experimental
    BB, PS, CM

    Participants receive brief bedside, peer support, and case management+ voucher intervention components.

    Behavioral: Brief Bedside · Behavioral: Peer Support · Behavioral: Case Management + Voucher

  • Experimental
    BB, PS, G

    Participants receive brief bedside, peer support, and SELF group intervention components.

    Behavioral: Brief Bedside · Behavioral: Peer Support · Behavioral: SELF Group Therapy Sessions

  • Experimental
    BB, PS

    Participants receive brief bedside and peer support intervention components.

    Behavioral: Brief Bedside · Behavioral: Peer Support

Interventions

  • BehavioralBrief Bedside

    * Initial support (in-hospital or shortly after if discharged early) * Needs assessment * Resource Sheet of Vetted Partners

  • BehavioralPeer Support

    * Weekly Check-ins * Status Check (Personal/family; Health; Mental Health; Spiritual, etc.) * Encouragement/Motivation (Staying safe, Doing right, etc.) * In-Person Visits (Home, Rehab, etc.) * Peer Social/Skill-building Activities (Money management, Job interviewing, Computer literacy, Creative arts, Critical thinking film discussions, etc.)

  • BehavioralCase Management + Voucher

    * Service Plan \& Referrals * Service Check-in/Follow up with partners and participants * Navigation of Health Care and Social Service Follow up appointments * Transportation Assistance * Basic life skills for service provision (riding bus/public transportation, zoom, etc.) * Vouchers for Immediate Needs/Obstacles

  • BehavioralSELF Group Therapy Sessions

    * Virtual Bi-weekly Group Therapy * SELF Curriculum- Trauma Focused Cognitive Behavioral Therapy * Lead by Therapists and Community Peer Volunteers * One-on-one Introductory/Intake Orientations

06

What researchers measure

Primary outcomes

  1. Change in Risky Firearm Behaviors

    Composite measure uses items adapted from the Tulane University National Youth Study capturing frequency and severity of risky firearm-related behaviors (i.e. carriage, threats, etc.) (0=Never; 6=20+ Times)

    Time frame: Baseline, 3-month, 6-month, 9-month, and 12 months

Secondary outcomes

  1. Change in PTSD

    The Posttraumatic Stress Disorder Checklist (PCL-5) is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD (0=Not at all; 4=Extremely)

    Time frame: Baseline, 3-month, 6-month, 9-month, and 12 months

  2. Change in Anxiety

    OASIS is a brief measure of overall anxiety severity and impairment. (0=No/None; 4=Constant/Extreme)

    Time frame: Baseline, 3-month, 6-month, 9-month, and 12 months

  3. Change in Depression

    The PHQ-9 is a validated, self-reported tool used for screening, diagnosing, and measuring the severity of depression. (0= Not at all; 3=Nearly every day)

    Time frame: Baseline, 3-month, 6-month, 9-month, and 12 months

  4. Change in Feasibility and Acceptability of Intervention

    Composite measure uses items adapted from the Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM), four-item measures of implementation outcomes. (1= Completely disagree; 5= Completely Agree)

    Time frame: 3-month, 6-month, 9-month, and 12 months

07

Study locations

1 of 1 sites recruiting
  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205, United States
    • Nakita Lovelady, PhD, MPH · Contact · nnlovelady@uams.edu · 501-526-6731
    • Joyce Raynor, BS · Contact · raynorjoyce@uams.edu · 501-372-3800
    • Nakita Lovelady, PhD, MPH · Principal investigator
    • Joyce Raynor, BS · Principal investigator
    • James Selig, PhD · Sub investigator
    • Geoffrey Curran, PhD · Sub investigator
    • Joshua Ellis, MD, MPH · Sub investigator
    • Austin Porter, DrPH, MPH · Sub investigator
    • Kelly Urban, PhD, MEd, RN CCRN-K, TCRN, CEN · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07539142
Lead sponsor
University of Arkansas
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Sponsor
First posted
Apr 20, 2026
Start date
Apr 20, 2026
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jun 2, 2026

Study contacts

Nakita Lovelady, PhD, MPH
Contact
nnlovelady@uams.edu
501-526-6731
Joyce Raynor, BS
Contact
raynorjoyce@uams.edu
501-372-3800
Nakita Lovelady, PhD, MPH
principal investigator · University of Arkansas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion